DatasetName,MRGBP_S(147) MRGBP_S(149) MRGBP_S(191) MRGBP_S(194) MRGBP_S(195) MRGBP_S(23) MRGBP_T(188),MRGBP_S(197)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,,
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),0.4701928712972309,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,0.48119986629232053,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,0.5231997705625725,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,
RKK2015_TNF-α/basal,0.4884563782342502,
JJ2018_Ratio H/M normalized pP2,0.4949706088642141,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,0.516126927634515,
HS2024_6_B_T3,0.5347559965848822,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,0.5280689842474394,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,,
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5106947627236883,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5263182596909212,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,0.5079142395017672,
FSO2013_Ratio M/L normalized Rep1___1,,
SAS2015_AZD/DMSO_Exp3,0.5144834527148372,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5323685302056003,
WZ2023_Pu_010_30min,0.5272848337122508,
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.5456948675249358,
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.5178471373261379,
JJ2018_Ratio H/L normalized___1,0.4985869010917644,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,,
AH2018_SILAC_MR_2_N,,
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.4495649924944214,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,,
EP2017_Pervanadate R#3 normalized log2 ratio,0.45810017316978696,
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5177346115854625,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,0.5183344586797114,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5260829836696066,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,
KBE2022_Log2_Ex_34_U,0.5453936982817355,
WZ2023_Pu_005_10min,0.5271787546673766,
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,0.5309168235145825,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,
WZ2023_Pu_025_30min,0.5327951332201137,
AH2018_SILAC_MR_2_X,,
HS2024_4_PD_T2,0.5224431638300512,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.6269787343906877,
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,0.5139457053642376,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.6091588621811707,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,
JJ2018_Ratio M/L normalized pP3,0.5273655200588125,
AH2018_SILAC_M_2_N,,
HS2024_7_PD_T2,0.5169566822755838,
FSO2013_Ratio H/L normalized Rep1___1,,
AH2018_LFQ_1_C,,
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.53871951398028,
HS2024_3_B_N1,0.5152501003827374,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.523188617130012,
CK2022_11 40-1,0.5302385405113716,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,
MV2014_Ratio H/M normalized A2___2 (2 min),0.532836702047272,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,,
FSO2013_Ratio H/L normalized Rep2,,
WZ2023_Pu_005_20min,0.5226540572051225,
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.6174993334894815,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,0.5058067044087118,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,0.512441761469697,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,0.5148720980526209,
FSO2013_Ratio M/L normalized Rep3___2,,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,0.518482669199982,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,0.5140406640774448,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,0.5189441242793594,
CK2022_1 200-1,0.5022825700802498,
PG2020_Intensity Mock_10h_D,0.5063743830635856,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,0.5121723467282404,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5142383789461823,
RCJD2014_5min_1,0.5368314672036645,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,0.5262642647925981,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,0.5215515171966227,
CR2017_Ratio Replicate 3.3,0.5232773511186581,
PG2020_Intensity 2h_C,0.4435420711881653,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,0.5141833898198128,
KBE2022_Log2_Ex_8_T,0.522060079999422,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,0.5134266029927579,
RN2012_L11,,
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,0.4953592218322093,
HS2024_5_PD_T1,0.5240716597484087,
AH2018_LFQ_M_2_C,,
CK2022_3 40-1,0.5345660708532005,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,0.516653675704051,
YA2020_Reporter_intensity_Cancer_No.5,,
HH2022_Reporter intensity 8,,
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,0.47295693607304357,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,0.5166595747754417,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,
YA2020_Reporter_intensity_Normal_No.1,,
HS2024_3_B_T1,0.5087166678201366,
JJ2018_Ratio H/L normalized___2,0.5745690106659422,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.5479188240867351,
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5042279789043927,
HS2024_8_I_T3,0.5000386592809244,
CF2017_EOC 3,0.5166776697737111,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,0.5299565228978843,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,0.5308779577953376,
WZ2023_Pu_010_20min,0.5230672474710667,
AS2011_Ratio H/L_3,,
CK2022_1 40-1,0.5336225792552779,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,0.5246583243299021,
KS2014_Intensity N3,0.5247069245456766,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,
FSO2013_Ratio H/M normalized Rep2,,
RAM2015_Log2 A,0.49857120129461296,
HS2024_8_PD_T1,0.5074335029158689,
JJ2018_Ratio H/L normalized pP2,0.5136990390928401,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.5099142310299484,
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,,
HS2024_7_I_T1,0.5124505507603205,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,0.48815265865522844,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,0.5136841040520982,
AH2018_SILAC_M_3_X,,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,0.5110146656204526,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.5338708834554919,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5264898843540724,
HS2024_6_B_N1,0.5124903127021193,
KBE2022_Log2_Ex_27_T,0.5089801679546283,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,0.5351467206604061,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,
NJH2025_Sub2_MICT_Post,0.49318228556817056,
AH2018_LFQ_4_C,,
DL2023_control-1,,
AR2021_ALG 10 μM,0.4844436622762984,
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,
EJN2021_4_Rest_Ins,,
RN2012_H05,0.5210597084159364,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5197158310391969,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,
JW2021_After_3,,
GF2025_P8_Sph,0.5168898834228124,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,0.5408963099311234,
AH2018_SILAC_2_N,,
CK2022_11 200-1,0.5008701938039372,
CK2022_12 200-1,0.5032295695066591,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,,
WZ2023_Su_010_20min,0.5200159915756092,
AH2018_TMTMS2_2_N,0.5185513333192212,
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5513346967844422,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,,
KS2014_Intensity N4,0.5137004568428188,
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,0.509179485554826,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,,
AST2020_anti-CD3+PDL2.2,,
PG2020_Intensity Mock_10h_A,0.4645974311804223,
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,0.49318228556817056,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,0.5213198863101628,
GF2025_P1_Adh,0.5109352988828887,
GF2025_P1_Sph,0.5273344702660692,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,0.48334374719720447,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.5299332581425995,
CF2017_EOC 1,0.5158658929195247,
CK2022_3 200-1,0.5020782360673869,
AH2018_LFQ_IT_3_C,,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,0.5015062931842336,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,0.5133741681269983,
HS2024_5_B_T1,0.5081533634245902,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,0.5143570415169058,
RB2022_6_PreStrength,,
CK2022_2 40-1,0.5338583631514492,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.5031283951946487,
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,0.5243424149007542,
AR2021_ALG 1 μM,0.4812193259312337,
HS2024_4_B_T1,0.5213136014032035,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,0.5164707256512692,
CR2017_Ratio Replicate 3.2,0.5102154179963966,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5132145708754663,
CK2022_9 16-1,0.5194103779565047,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,0.5074209721909815,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,,
CK2022_16 16-1,0.5235930453693335,
FS2019_db/db3,0.5020190256467798,
CK2022_15 40-1,0.5358079393504408,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5237755929855608,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5515068160872725,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,
HS2024_5_PD_T3,0.5518945949692574,
AH2018_TMTMS3_3_X,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5567394394260313,
AH2018_LFQ_M_1_N,,
KBE2022_Log2_Ex_27_U,0.517889668986425,
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),0.5070740266587176,
AH2018_SILAC_M_1_N,,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.48102574194074876,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,0.5232156478893286,
RN2012_L13,0.5040749737330084,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.5196670824058124,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,0.5222919205587208,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,0.5047105729906185,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,0.5313231593833045,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5384810875187418,
HH2022_Reporter intensity 6,,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.4751677462905231,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5172058259352592,
GF2025_P3_Adh,0.5023416063382985,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5234095928478476,
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.5116137320014584,
KBE2022_Log2_Ex_19_U,0.5562084037543524,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,
YA2020_Reporter_intensity_Cancer_No.1,,
AST2020_Control,,
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,0.506780346611633,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,,
HS2024_8_B_T2,0.5071568822687114,
AH2018_LFQ_1_X,,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,0.513250098470414,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5064314798526814,
HH2022_Reporter intensity 1,,
HH2022_Reporter intensity 2,,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,0.5553391469342874,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5133107585112713,
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.4955489385391975,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,,
AR2021_KD 72h,0.516540269682445,
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5220307149855861,
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,,
KBE2022_Log2_Ex_9_U,0.5209868422436176,
AH2018_SILAC_M_3_N,,
KBE2022_Log2_Ex_13_T,0.5259580353165921,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.510622529156072,
CF2017_OSE 29,0.4888877860538981,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,0.5036403289308549,
PG2020_Intensity 10h_A,,
RN2012_L12,,
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,
SAS2015_PLX/AZD_Exp1,0.5078833069671591,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,0.53180008767792,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.5032187633528459,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,
FSO2013_Ratio H/M normalized Rep2___2,,
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5386183460640872,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5177656084004594,
RB2022_1_PreSprint,,
HS2024_4_I_N1,0.48874261193294,
CK2022_7 200-1,0.5080501055570944,
CK2022_5 200-1,0.5106666695178662,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,,
AH2018_SILAC_MR_1_X,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,0.5286398374929158,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5342896590596151,
AH2018_SILAC_3_C,,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,,
CK2022_4 16-1,0.5197845627761922,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,
SAS2015_PLX/DMSO_Exp1,0.5033943466984204,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,0.5409268120814427,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.48894503245535287,
FSO2013_Ratio H/L normalized Rep3,,
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,0.47281914624894156,
JJ2018_Ratio M/L normalized,0.5350581352838258,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,0.4962848513863257,
HS2024_6_B_N2,0.5151152850634856,
KBE2022_Log2_Ex_9_T,0.514430981643394,
AH2018_SILAC_IT_2_N,,
AH2018_SILAC_IT_1_X,,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,0.49056694738983586,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.5082209121741517,
WZ2023_Pe_025_20min,0.5263012360233381,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,
HS2024_4_I_N2,0.5060351372182704,
AH2018_TMTMS2_3_N,0.5190032545311193,
RN2012_H06,0.5178554796184603,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,0.5252560395614942,
WZ2023_Su_005_30min,0.5156229247135747,
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,0.5515391414460662,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.4753296260377943,
WZ2023_Su_025_10min,0.5278990674750347,
AH2018_LFQ_IT_4_X,,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5204026328610024,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,
EP2017_Pervanadate R#1 log2 ratio,0.46438358029161453,
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.51492981770855,0.5969013599016649
MV2014_Ratio H/M normalized A2___1 (2 min),0.49820579041561314,
PG2020_Intensity 8h_D,,
LY2019_P7+,0.4569609489783681,
EP2017_Untreated R#1 normalized log2 ratio,0.518580722035474,
RN2012_L10,,
PG2020_Intensity 4h_C,0.47429686047359176,
EP2017_Mitotic R#3 normalized log2 ratio,0.5128417608844019,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5295544649293712,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,
HS2024_4_B_T3,0.5478898653579616,
NJH2024_Sub2_HIIT_Post,0.47295693607304357,
HS2024_8_B_N2,0.5061821594430146,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,0.513594684693471,
HS2024_8_I_T2,0.5062601717373126,
KBE2022_Log2_Ex_6_U,0.5302573474589825,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.4966622844138571,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5078379803131903,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5137905770808813,
GF2025_P9_Sph,0.5178861726089735,
CK2022_6 200-1,0.5096183050555111,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,0.4860249092584792,
NJH2024_Sub2_MICT_Mid,0.4962848513863257,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,0.5119590610837204,
SAS2015_AZD/DMSO_Exp1,0.5030574332411115,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,0.529067316076613,
HS2024_3_B_T3,0.5005484307423468,
MV2014_Ratio L/H normalized A3___2 (2 min),0.5398345114594274,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.4383492167404292,
EP2017_Untreated R#3 normalized log2 ratio,0.5006506407842964,
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5106648739485068,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.6217897742931069,
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,0.5077408976743193,
EP2017_Pervanadate R#2 normalized log2 ratio,0.45290523268907057,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,0.5107424220859126,
KBE2022_Log2_Ex_29_T,0.514490613555219,
HS2024_7_I_T2,0.5127874844033751,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,0.5496353520590698,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,0.5681795439243619,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5022876442455271,
PG2020_Intensity CT_C,0.48325977645842844,
ZCP2016_Ratio H/L Rep 1,0.4766514885059455,
FS2019_db/db2,0.5197072332250656,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.5825638768921478,
EP2017_Untreated R#3 log2 ratio,0.49365483269250815,
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5723532712007062,
HS2024_8_PD_T2,0.5099920310082228,
FS2019_Ctr2,0.5195033775453322,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,0.4983016852120624,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5139905555569348,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,0.5291773286333761,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.6080084732102431,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5054931733380115,
YA2020_Reporter_intensity_Normal_No.2,,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,0.5127593680340754,
HS2024_3_PD_T3,0.5167977500303754,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.4927001529329017,
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,,
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5359050958232616,
CK2022_2 16-1,0.5202887797546442,
RAM2015_Log2 B,0.4878489798939417,
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,,
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,0.5263648218124984,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,0.5439024412212515,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,0.520861578670892,
PG2020_Intensity Mock_10h_B,0.4609621846929178,
WZ2023_Su_025_30min,0.5303289023317064,
AH2018_LFQ_4_N,,
CR2017_Ratio Replicate 1.2,0.5878580314864658,
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,0.5227538195090818,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,,
AH2018_SILAC_M_1_X,,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5191734293059158,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5406462235545254,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,0.5427054400417842,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5220263557723203,
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,0.49795142160754047,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.5210870035299636,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,0.49720936848341857,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,0.5359065479163567,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,
AH2018_LFQ_2_X,,
PG2020_Intensity 2h_B,0.46413972536365344,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5068114743838923,0.7237576004167122
GF2025_P3_Sph,0.502959808298194,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,0.5023943493886514,
CR2017_Ratio Replicate 2.4,0.5765712058600977,
ZQ2022_N1,,
LY2019_P6-,0.5199015483138207,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.5092511960820082,
AH2018_LFQ_3_N,,
RKK2015_TNF-α/IKKb,0.4904813286271601,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.5239200925944076,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,0.5644674236626085,
CK2022_7 40-1,0.5319760950474093,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,0.531107520483763,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,0.5061312581312278,
WZ2023_Su_025_20min,0.5294950557132375,
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,0.5287156698754785,
LY2019_P8-,0.548085265057879,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,,
NJH2024_Sub2_HIIT_Pre,0.49795142160754047,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,0.535030621913699,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,
RB2022_8_PreEndurance,,
HS2024_3_B_N2,0.5099495340259462,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.46013589639507774,
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,0.4543494895035956,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,
AH2018_LFQ_M_4_C,,
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,0.5203522905666922,
CK2022_6 40-1,0.533332354611039,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5342003938939285,
LY2019_P3-,0.5166586787095251,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),0.5078647474938082,
WZ2023_Pe_005_30min,0.5269595672639461,
HS2024_8_PD_T3,0.5086922501801142,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.4805380302885922,
FS2019_Ctr3,0.5261707496212557,
WZ2023_Pu_025_20min,0.5215187318096596,
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.505008917635872,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,0.4874899463259615,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.5217626563859759,
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,,
HS2024_8_I_N2,0.5157887826570907,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,
LY2019_P8+,0.5463425677551105,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,0.4948124495908233,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,,
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5491456792191468,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5040865230384559,
LY2019_P2-,0.5313583311671938,
AH2018_LFQ_IT_1_X,,
JJ2018_Ratio H/L normalized pP3___1,0.5203466645590326,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5274735696066377,
AST2020_Control.2,,
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,0.4904005063946221,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,0.5242178846588142,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,0.5349589589729631,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.49540556953170406,
HS2024_5_B_T2,0.5151241925484021,
HS2024_6_I_T1,0.5068538625285174,
HS2024_5_B_T3,0.5178160910414364,
JJ2018_Ratio H/M normalized pP1___1,0.5218210374979797,
KBE2022_Log2_Ex_36_U,0.5262942994457236,
AH2018_TMTMS3_3_N,,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,,
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5160323244422369,
KBE2022_Log2_Ex_36_T,0.5135515790289843,
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5281894800749387,
KS2014_Intensity C2,0.5268823551722867,0.7488295178667111
FSO2013_Ratio H/L normalized Rep1___2,,
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.5383010828857785,
CK2022_9 200-1,0.5019110102188977,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,0.5494795394049385,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5022501086330423,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,0.5240302597710461,
RBK2021_1332T Late,,
LY2019_P1-,0.516335804346509,
RKK2015_TNF-α/basal.1,0.5127878314710653,
RKK2015_TNF-α/TNF-α+SC-514,0.5379663025935633,
CR2017_Ratio Replicate 2.5,0.6034297813879788,
HS2024_3_I_T3,0.5240500552092265,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5101759320259822,
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5569322094083244,
FSO2013_Ratio H/M normalized Rep3___2,,
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5113432366041637,
RKK2015_SC-514/basal,0.4761658569897317,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5225672867919361,
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,0.5275072969343434,
KS2014_Intensity N1,0.5155534736041919,
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5148477757481722,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,0.5446170663527933,
AH2018_SILAC_MR_2_C,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,0.47826378500332584,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,
JJ2018_Ratio H/M normalized___1,0.5233781600358586,
RCJD2014_15min_2,0.502554358202827,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,,
HS2024_5_B_N2,0.5423019336701793,
HS2024_5_I_N1,0.5378869028791936,
HS2024_6_I_N1,0.5146885796682648,
AR2021_KD 48h,0.5596031221637999,
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,0.5305628354465719,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5298622946777266,
KBE2022_Log2_Ex_29_U,0.5315554085895821,
HS2024_7_B_T1,0.5152580687399292,
AH2018_LFQ_M_2_X,,
AH2018_LFQ_IT_4_N,,
CK2022_15 200-1,0.5082372733078949,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,0.5476300475247224,
JJ2018_Ratio M/L normalized pP3___1,0.5065207361248513,
KBE2022_Log2_Ex_34_T,0.5345967941071913,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.4979533020707457,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.500443737390894,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),0.49446005091376083,
WZ2023_Su_010_30min,0.5229703933449293,
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.46237439547014375,
HS2024_8_B_T3,0.5202406467011408,
YA2020_Reporter_intensity_Cancer_No.3,,
KBE2022_Log2_Ex_44_U,0.5456432328785341,
WZ2023_Pe_010_20min,0.5311241565895181,
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,0.5294731711715092,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,0.5127106065144745,
KS2014_Intensity C1,0.520091533776965,
FSO2013_Ratio H/M normalized Rep3___1,,
AH2018_SILAC_M_3_C,,
RKK2015_TNF-α+IKKb/TNF-α,0.5139141330696763,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,
AH2018_SILAC_M_2_X,,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5160521426545769,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5237557668932703,
PG2020_Intensity 6h_C,0.496158293530411,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,0.5017643343998065,
AH2018_LFQ_M_3_N,,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.521831754156584,
CK2022_15 16-1,0.5228677098341142,
CK2022_3 16-1,0.5203461390641663,
LY2019_P4-,0.514903704662567,
FSO2013_Ratio H/L normalized Rep3___2,,
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,0.5146527211958314,
GF2025_P8_Adh,0.5435419581216175,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,0.5219649425400195,
GF2025_P5_Sph,0.5220398161486318,
CK2022_10 16-1,0.5184875129468794,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,0.4851521242750243,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,0.5596894156119294,
IMM2018_normalised rep. int. CDK5L-1,0.5280964953276268,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5163393145759484,
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.5002871068931439,
AR2021_L41 10 μM,0.5175456814379651,
CF2017_EOC 2,0.5106288407787211,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,0.49720936848341857,
HS2024_3_PD_T2,0.5279038909614193,
CK2022_6 16-1,0.5237826992623872,
ZX2022_CB treated Replicate 1,0.5153440026770777,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5196761466634402,
AR2021_L41 1 μM,0.5272074196489853,
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5150118962190858,
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,0.5088990242233294,
KS2014_Intensity C4,0.520927589237912,
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.5203066407794947,
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,0.49716824785393177,
MV2014_Ratio H/M normalized B2___1 (5 min),0.4927668149648578,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,0.5120881366935747,
SAS2015_PLX/DMSO_Exp3,0.506891143847693,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,0.4851521242750243,
AH2018_LFQ_M_3_C,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,
WZ2023_Pu_025_10min,0.5257043739441112,
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,0.5092526543184323,
FSO2013_Ratio M/L normalized Rep3___1,,
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,0.477722761016328,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,0.5024349471571025,
WZ2023_Pe_010_30min,0.5283052900204035,
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,
KS2014_Intensity C6,0.5227019396976849,
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,0.5316837734279175,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,0.5150095433393534,
JJ2018_Ratio H/M normalized pP1,0.5220813464939656,
CK2022_16 40-1,0.5356855089925703,
AH2018_SILAC_IT_2_C,,
CK2022_5 40-1,0.5334428490671469,
AH2018_LFQ_3_X,,
UK2020_UA_3,,
LY2019_P7-,0.49704492286266583,
GF2025_P5_Adh,0.5129502891103377,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.6101236241837336,
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,0.518589015126856,
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.4775907257545345,
PG2020_Intensity CT_B,0.4987726914753072,
JJ2018_Ratio M/L normalized___2,0.5588994533520646,
AH2018_SILAC_MR_1_N,,
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,0.5176701765277238,
AH2018_LFQ_3_C,,
JJ2018_Ratio M/L normalized pP3___2,0.566541903664992,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,
YA2020_Reporter_intensity_Cancer_No.4,,
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,0.498765653004451,
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.5290489191566914,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),0.49591907069286645,
JJ2018_Ratio M/L normalized___1,0.5117054780527907,
FR2021_Intensity.H,,
CK2022_14 16-1,0.5230645226566899,
AST2020_anti-CD3+PDL2,,
MV2014_Ratio M/L normalized B1___1 (5 min),0.499304565859155,
KBE2022_Log2_Ex_19_T,0.5246254436909863,
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,,
HS2024_8_I_T1,0.5092990558275498,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5162486241110099,
AH2018_TMTMS2_1_X,0.5186067294894781,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,0.4746505222471109,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,0.5091347487413691,
HH2022_Reporter intensity 4,,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,0.5460684696836421,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,0.595738848114026,
CF2017_FTE 15,0.49970710826533354,
HS2024_4_I_T3,0.5123689517449291,
AH2018_SILAC_1_X,,
PG2020_Intensity 10h_B,,
AH2018_TMTMS3_1_X,,
CF2017_FTE 14,0.4889562834758784,
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,0.4871217573881224,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.4719241010565843,
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.5245937322892996,
EP2017_Untreated R#2 normalized log2 ratio,0.520092594610936,
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.46786049111971423,
HS2024_5_I_N2,0.5171287513291075,
SAS2015_PLX/AZD_Exp3,0.5028028424885493,
EP2017_Pervanadate R#2 log2 ratio,0.45523523204753547,
AS2011_Ratio H/L Normalized RNAi_2_1,,
